Related Experiment Videos
Quinolones in the treatment of typhoid fever
1Pfizer Pharmaceutical Group, Ortaköy, Istanbul, Turkey. akalie@pfizer.com
Abstract:
Typhoid fever is a severe systemic disease. Treatment with appropriate antibiotics is essential for enteric fever. Development and rapid dissemination of resistance to chloramphenicol, ampicillin, and cotrimoxazole have complicated the treatment of enteric fever. Therapeutic options for the treatment of multidrug-resistant strains are limited to third generation cephalosporins or fluoroquinolone antibiotics. Recent clinical experiences have shown that quinolones are the drugs of choice for treatment of enteric fever. Studies have shown that shorter courses may be sufficient to cure uncomplicated typhoid fever.
Insights
Typhoid fever treatment is complicated by antibiotic resistance. Quinolone antibiotics are now the preferred choice for treating drug-resistant typhoid fever, with shorter courses potentially effective.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Typhoid fever is a severe systemic illness requiring effective antibiotic treatment.
- Increasing resistance to traditional antibiotics like chloramphenicol, ampicillin, and cotrimoxazole complicates therapeutic choices.
- Multidrug-resistant strains necessitate alternative treatment strategies.
Purpose of the Study:
- To review the current therapeutic options for typhoid fever, particularly in the context of antimicrobial resistance.
- To evaluate the efficacy of fluoroquinolone antibiotics as a primary treatment for enteric fever.
Main Methods:
- Review of recent clinical experiences and published studies on typhoid fever treatment.
- Analysis of treatment outcomes for multidrug-resistant strains.
- Evaluation of antibiotic efficacy, focusing on quinolone and third-generation cephalosporin classes.
Main Results:
- Fluoroquinolone antibiotics have emerged as the drugs of choice for treating enteric fever.
- Third-generation cephalosporins offer an alternative for multidrug-resistant strains.
- Shorter treatment courses may be sufficient for uncomplicated cases of typhoid fever.
Conclusions:
- Quinolones represent a critical therapeutic advance for managing typhoid fever, especially resistant strains.
- Optimizing treatment duration can improve patient outcomes and potentially reduce antibiotic pressure.
- Continued surveillance of antimicrobial resistance patterns is essential for guiding treatment strategies.